Search research articles
Contact Us
Filters
Showing results (91-100 of 172) with videos related to
Page
of 18
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 21, 2019
Nivolumab Monotherapy and Nivolumab Plus Ipilimumab in Recurrent Small Cell Lung Cancer: Results From the CheckMate 032 Randomized Cohort
Neal E Ready, Patrick A Ott, Matthew D Hellmann, et al.
Plos Medicine
|
May 30, 2017
Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: An exploratory multi-omic analysis
Alexandra Snyder, Tavi Nathanson, Samuel A Funt, et al.
JCO Precision Oncology
|
June 14, 2019
Immunophenotype and Response to Immunotherapy of RET-Rearranged Lung Cancers
Michael Offin, Robin Guo, Stephanie L Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 10, 2021
Immunotherapy-Mediated Thyroid Dysfunction: Genetic Risk and Impact on Outcomes with PD-1 Blockade in Non-Small Cell Lung Cancer
Jia Luo, Victoria L Martucci, Zoe Quandt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 11, 2016
Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets
Natasha Rekhtman, Maria C Pietanza, Matthew D Hellmann, et al.
Cancer Chemotherapy and Pharmacology
|
July 2, 2013
Risk of hemoptysis in patients with resected squamous cell and other high-risk lung cancers treated with adjuvant bevacizumab
Matthew D Hellmann, Jamie E Chaft, Valerie Rusch, et al.
The Oncologist
|
August 17, 2023
Outcomes of Combination Platinum-Doublet Chemotherapy and Anti-PD(L)-1 Blockade in KRASG12C-Mutant Non-Small Cell Lung Cancer
Arielle Elkrief, Biagio Riccuiti, Joao V Alessi, et al.
Journal for Immunotherapy of Cancer
|
July 24, 2023
Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: a cohort study
Arielle Elkrief, Joao M Victor Alessi, Biagio Ricciuti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 29, 2022
Systemic and Oligo-Acquired Resistance to PD-(L)1 Blockade in Lung Cancer
Adam J Schoenfeld, Hira A Rizvi, Danish Memon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 6, 2019
First-in-Humans Imaging with <sup>89</sup>Zr-Df-IAB22M2C Anti-CD8 Minibody in Patients with Solid Malignancies: Preliminary Pharmacokinetics, Biodistribution, and Lesion Targeting
Neeta Pandit-Taskar, Michael A Postow, Matthew D Hellmann, et al.
Page
of 18
Search research articles
Search
Showing results (91-100 of 172) with videos related to
Sort By:
Page
of 18
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 21, 2019
Nivolumab Monotherapy and Nivolumab Plus Ipilimumab in Recurrent Small Cell Lung Cancer: Results From the CheckMate 032 Randomized Cohort
Neal E Ready, Patrick A Ott, Matthew D Hellmann, et al.
Plos Medicine
|
May 30, 2017
Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: An exploratory multi-omic analysis
Alexandra Snyder, Tavi Nathanson, Samuel A Funt, et al.
JCO Precision Oncology
|
June 14, 2019
Immunophenotype and Response to Immunotherapy of RET-Rearranged Lung Cancers
Michael Offin, Robin Guo, Stephanie L Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 10, 2021
Immunotherapy-Mediated Thyroid Dysfunction: Genetic Risk and Impact on Outcomes with PD-1 Blockade in Non-Small Cell Lung Cancer
Jia Luo, Victoria L Martucci, Zoe Quandt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 11, 2016
Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets
Natasha Rekhtman, Maria C Pietanza, Matthew D Hellmann, et al.
Cancer Chemotherapy and Pharmacology
|
July 2, 2013
Risk of hemoptysis in patients with resected squamous cell and other high-risk lung cancers treated with adjuvant bevacizumab
Matthew D Hellmann, Jamie E Chaft, Valerie Rusch, et al.
The Oncologist
|
August 17, 2023
Outcomes of Combination Platinum-Doublet Chemotherapy and Anti-PD(L)-1 Blockade in KRASG12C-Mutant Non-Small Cell Lung Cancer
Arielle Elkrief, Biagio Riccuiti, Joao V Alessi, et al.
Journal for Immunotherapy of Cancer
|
July 24, 2023
Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: a cohort study
Arielle Elkrief, Joao M Victor Alessi, Biagio Ricciuti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 29, 2022
Systemic and Oligo-Acquired Resistance to PD-(L)1 Blockade in Lung Cancer
Adam J Schoenfeld, Hira A Rizvi, Danish Memon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 6, 2019
First-in-Humans Imaging with <sup>89</sup>Zr-Df-IAB22M2C Anti-CD8 Minibody in Patients with Solid Malignancies: Preliminary Pharmacokinetics, Biodistribution, and Lesion Targeting
Neeta Pandit-Taskar, Michael A Postow, Matthew D Hellmann, et al.
Page
of 18